Double blind clinical trial pain evaluation of a new drug with corticosteroid base as inter-appointment dressing in root canal therapy of human’s teeth

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190106042250N1

Enrollment

100

Registered

2019-12-31

Start date

2019-01-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irreversible pulpitis.

Interventions

Intervention 1: Intervention group: Patients with irreversible pulpitis in permanent teeth requiring root canal treatment.After the pulpectomy and cleaning and shaping of the canal the drug is inserte

Eligibility

Sex/Gender

All

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: no systemic disease permanent and mature vital tooth clinical indication for two visit treatment

Exclusion criteria

Exclusion criteria: Systemic disease that can impair the healing process of the tissue. The patient is unable to understanding consent form and understanding the form of pain assessment. Tooth that is not possible during the first session of treatment, cleansing and shaping of all canals . A tooth that does not have enough tissue to maintain temporary repair History of previous root canal treatment in treated teeth

Design outcomes

Primary

Measure	Time frame
Spontaneous tooth pain one week after treatment. Timepoint: the first week after treatment. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohammad mehdi panjali zadeh

Kerman University of Medical Sciences

dentistryschool@kmu.ac.ir0098 32 ????????

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026